
    
      This study is designed to test the safety and tolerability of Fecal Microbiota Transplant
      (FMT) in HIV infected individuals on stable antiretroviral therapy (ART). Additionally, the
      study will examine potential effects of FMT on HIV immune activation, which has been linked
      to HIV disease progression.
    
  